Literature Citations
1. Synthesis and Mycobacterial Evaluation of 5-Substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one Derivatives. Agre, N., M. Degani, A. Gupta, S. Bhakta, and M.K. Ray. Archiv der Pharmazie, 2019. 352(9): p. e1900068. PMID[31339194].
[PubMed]. TB_08_2019.
2. Synthesis and Antimicrobial Activity of a Phenanthroline-Isoniazid Hybrid Ligand and its Ag(+) and Mn(2+) Complexes. Ahmed, M., D. Rooney, M. McCann, M. Devereux, B. Twamley, A.C.M. Galdino, L.S. Sangenito, L.O.P. Souza, M.C. Lourenco, K. Gomes, and A.L.S. Dos Santos. BioMetals, 2019. 32(4): p. 671-682. PMID[31230149].
[PubMed]. TB_08_2019.
3. New N-Phenylacetamide-incorporated 1,2,3-Triazoles: [Et3NH][OAc]-mediated Efficient Synthesis and Biological Evaluation. Akolkar, S.V., A.A. Nagargoje, V.S. Krishna, D. Sriram, J.N. Sangshetti, M. Damale, and B.B. Shingate. RSC Advances, 2019. 9(38): p. 22080-22091. ISI[000476751400056].
[WOS]. TB_08_2019.
4. Decavanadate is a More Potent Growth Inhibitor of Two Mycobacteria Strains than Other Oxovanadates. Arhouma, Z., N. Samart, S. Kumar, H. Murakami, D. Crick, and D. Crans. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478860500725].
[WOS]. TB_08_2019.
5. Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-Tb. Campanico, A., M.P. Carrasco, M. Njoroge, R. Seldon, K. Chibale, J. Perdigao, I. Portugal, D.F. Warner, R. Moreira, and F. Lopes. ChemMedChem, 2019. 14(16): p. 1537-1546. PMID[31294529].
[PubMed]. TB_08_2019.
6. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on Mycobacterium tuberculosis May Be Affected Due to Its Methylation by Methyltransferase Rv0560c. Chen, C., X. Han, Q. Yan, C. Wang, L. Jia, A. Taj, L. Zhao, and Y. Ma. Frontiers in Cellular and Infection Microbiology, 2019. 9: p. 251. PMID[31380295]. PMCID[PMC6652808].
[PubMed]. TB_08_2019.
7. Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-drug Resistance Mycobacterium tuberculosis Isolates from China. Chen, X., G. He, S. Wang, S. Lin, J. Chen, and W. Zhang. Frontiers in Microbiology, 2019. 10: p. 1741. PMID[31417530]. PMCID[PMC6685394].
[PubMed]. TB_08_2019.
8. Discovery of Novel Anti-tubercular Agent for the Treatment of MDR/XDR Tb. Choi, J., S. Kang, Y.M. Kim, I. Choi, A. Lee, G. Jin, V. Delorme, and K. Park. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478861202807].
[WOS]. TB_08_2019.
9. Next-generation Bedaquiline for the Treatment of Tuberculosis. Choi, P., H. Sutherland, A. Tong, D. Conole, A. Blaser, C. Cooper, S. Franzblau, A. Upton, W. Denny, and B. Palmer. Abstracts of Papers of the American Chemical Society, 2019. 257. ISI[000478861202648].
[WOS]. TB_08_2019.
10. Design, Synthesis, Antitubercular and Antiviral Properties of New Spirocyclic Indole Derivatives. Cihan-Ustundag, G., L. Naesens, D. Satana, G. Erkose-Genc, E. Mataraci-Kara, and G. Capan. Monatshefte fur Chemie, 2019. 150(8): p. 1533-1544. ISI[000477624300016].
[WOS]. TB_08_2019.
11. Design, Synthesis, and Antimycobacterial Activity of Novel Ciprofloxacin Derivatives. Cilliers, P., R. Seldon, F.J. Smit, J. Aucamp, A. Jordaan, D.F. Warner, and D.D. N'Da. Chemical Biology and Drug Design, 2019. 94(2): p. 1518-1536. PMID[31033220].
[PubMed]. TB_08_2019.
12. Rifamycin Derivatives Active against Pathogenic Rapidly-growing Mycobacteria. Combrink, K.D., A.R. Ramos, S. Spring, S. Schmidl, K. Elizondo, P. Morin, B. De Jesus, and F.P. Maurer. Bioorganic & Medicinal Chemistry Letters, 2019. 29(16): p. 2112-2115. PMID[31281018].
[PubMed]. TB_08_2019.
13. Targeting the Mycobacterium tuberculosis Transpeptidase LdtMt2 with Cysteine-reactive Inhibitors Including Ebselen. de Munnik, M., C.T. Lohans, P.A. Lang, G.W. Langley, T.R. Malla, A. Tumber, C.J. Schofield, and J. Brem. Chemical Communications, 2019. 55(69): p. 10214-10217. PMID[31380528].
[PubMed]. TB_08_2019.
14. Proteomic and Morphologic Evidence for Taurine-5-bromosalicylaldehyde Schiff Base as an Efficient Anti-mycobacterial Drug. Ding, W., H. Zhang, Y. Xu, L. Ma, and W. Zhang. Journal of Microbiology and Biotechnology, 2019. 29(8): p. 1221-1229. PMID[31370112].
[PubMed]. TB_08_2019.
15. Synthesis, Docking, and Pharmacological Evaluation of Derivatives of alpha-Aminoketones Appended to Sydnones as Potent Antitubercular and Antifungal Scaffolds. Dorababu, A., R.R. Kamble, S.K.J. Shaikh, S.M. Somagond, P.K. Bayannavar, and S.D. Joshi. Journal of Heterocyclic Chemistry, 2019. 2019: 3630. ISI[000479688400001].
[WOS]. TB_08_2019.
16. Design, Synthesis and Biological Evaluation of Some 2-(6-Nitrobenzo[d]thiazol-2-ylthio)-N-benzyl-N-(6-nitrobenzo[d]thiazol-2-yl) acetamide Derivatives as Selective DprE1 Inhibitors. Gawad, J. and C. Bonde. Synthetic Communications, 2019. 49(20): p. 2696-2708. ISI[000479938400001].
[WOS]. TB_08_2019.
17. Chemical Investigation of the Secondary Metabolites of Streptomyces sp. 4205. Gu, C.Z., J. Lv, S.H. Yuan, Y.Y. Song, C.R. Yang, Y.J. Zhang, and R.S. Zeng. Natural Product Communications, 2019. 14(6): 3pp. ISI[000475765700074].
[WOS]. TB_08_2019.
18. Secondary Metabolites from the Mangrove Sediment-derived Fungus Penicillium pinophilum SCAU037. He, F., X. Li, J.H. Yu, X. Zhang, X. Nong, G. Chen, K. Zhu, Y.Y. Wang, J. Bao, and H. Zhang. Fitoterapia, 2019. 136: 104177. PMID[31128244].
[PubMed]. TB_08_2019.
19. Detection of Novel Mutations Associated with Independent Resistance and Cross-resistance to Isoniazid and Prothionamide in Mycobacterium tuberculosis Clinical Isolates. Islam, M.M., Y. Tan, H.M.A. Hameed, Z. Liu, C. Chhotaray, Y. Liu, Z. Lu, X. Cai, Y. Tang, Y. Gao, G. Surineni, X. Li, S. Tan, L. Guo, X. Cai, W.W. Yew, J. Liu, N. Zhong, and T. Zhang. Clinical Microbiology and Infection, 2019. 25(8): e1041. PMID[30583053].
[PubMed]. TB_08_2019.
20. Nu-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G. Kidwai, S., R. Bouzeyen, S. Chakraborti, N. Khare, S. Das, T. Priya Gosain, A. Behura, C.L. Meena, R. Dhiman, M. Essafi, A. Bajaj, D.K. Saini, N. Srinivasan, D. Mahajan, and R. Singh. Antimicrobial Agents and Chemotherapy, 2019. 63(9): e00996-00919. PMID[31285226].
[PubMed]. TB_08_2019.
21. Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-tuberculosis (Tb) Activities of Clofazimine. Lentz, F., N. Reiling, G. Spengler, A. Kincses, A. Csonka, J. Molnar, and A. Hilgeroth. Molecules, 2019. 24(16): 12pp. PMID[31398786].
[PubMed]. TB_08_2019.
22. Dual-pharmacophore Pyrithione-containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis. Lopez Quezada, L., K. Li, S.L. McDonald, Q. Nguyen, A.J. Perkowski, C.W. Pharr, B. Gold, J. Roberts, K. McAulay, K. Saito, S. Somersan Karakaya, P.E. Javidnia, E. Porras de Francisco, M.M. Amieva, S.P. Di Az, A. Mendoza Losana, M. Zimmerman, H.H. Liang, J. Zhang, V. Dartois, S. Sans, S. Lagrange, L. Goullieux, C. Roubert, C. Nathan, and J. Aube. ACS Infectious Diseases, 2019. 5(8): p. 1433-1445. PMID[31184461].
[PubMed]. TB_08_2019.
23. Ferrocene Derivatives as Anti-infective Agents. Ludwig, B.S., J.D.G. Correia, and F.E. Kuhn. Coordination Chemistry Reviews, 2019. 396: p. 22-48. ISI[000475993800002].
[WOS]. TB_08_2019.
24. Identification of Potential Inhibitors for AroG against Mycobacterium tuberculosis. Madhulitha, N.R., K.S. Kumar, C. Pasala, S. Pakala, and A. Umamaheswari. Journal of Biomolecular Structure & Dynamics, 2019. 37: p. 29-30. ISI[000477005700052].
[WOS]. TB_08_2019.
25. Mannopyranoside Glycolipids Inhibit Mycobacterial and Biofilm Growth and Potentiate Isoniazid Inhibition Activities in M. smegmatis. Mahapa, A., G.C. Samanta, K. Maiti, D. Chatterji, and N. Jayaraman. ChemBioChem, 2019. 20(15): p. 1966-1976. PMID[30951240].
[PubMed]. TB_08_2019.
26. Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate kinase. Makafe, G.G., M. Hussain, G. Surineni, Y. Tan, N.K. Wong, M. Julius, L. Liu, C. Gift, H. Jiang, Y. Tang, J. Liu, S. Tan, Z. Yu, Z. Liu, Z. Lu, C. Fang, Y. Zhou, J. Zhang, Q. Zhu, J. Liu, and T. Zhang. Cell Chemical Biology, 2019. 26(8): p. 1187-1194. PMID[31204286].
[PubMed]. TB_08_2019.
27. In Vitro Activity of Bedaquiline against Slow-growing Nontuberculous Mycobacteria. Martin, A., I.T. Godino, D.A. Aguilar-Ayala, V. Mathys, N. Lounis, and H.R. Villalobos. Journal of Medical Microbiology, 2019. 68(8): p. 1137-1139. PMID[31210631].
[PubMed]. TB_08_2019.
28. Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-carboxanilides: Comparative Molecular Surface Analysis. Michnova, H., S. Pospisilova, T. Gonec, I. Kapustikova, P. Kollar, V. Kozik, R. Musiol, I. Jendrzejewska, J. Vanco, Z. Travnicek, A. Cizek, A. Bak, and J. Jampilek. Molecules, 2019. 24(16): e2991. PMID[31426567].
[PubMed]. TB_08_2019.
29. Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates. Mok, S., M.M. Hannan, L. Nolke, P. Stapleton, N. O'Sullivan, P. Murphy, A.M. McLaughlin, E. McNamara, M.M. Fitzgibbon, and T.R. Rogers. Antimicrobial Agents and Chemotherapy, 2019. 63(9): e00755-00719. PMID[31262760].
[PubMed]. TB_08_2019.
30. Synthesis and Biological Evaluation of Aryl phosphoramidate Prodrugs of Fosfoxacin and Its Derivatives. Munier, M., D. Tritsch, D. Lievremont, M. Rohmer, and C. Grosdemange-Billiard. Bioorganic Chemistry, 2019. 89: 103012. PMID[31174039].
[PubMed]. TB_08_2019.
31. 8-Hydroxyquinolines are Bactericidal against Mycobacterium tuberculosis. Odingo, J.O., J.V. Early, J. Smith, J. Johnson, M.A. Bailey, M. Files, J. Guzman, J. Ollinger, A. Korkegian, A. Kumar, Y. Ovechkina, and T. Parish. Drug Development Research, 2019. 80(5): p. 566-572. PMID[30893501].
[PubMed]. TB_08_2019.
32. Synthesis, Computational Studies, Antimycobacterial and Antibacterial Properties of Pyrazinoic acid-Isoniazid Hybrid Conjugates. Panda, S.S., A.S. Girgis, B.B. Mishra, M. Elagawany, V. Devarapalli, W.F. Littlefield, A. Samir, W. Fayad, N.G. Fawzy, A.M. Srour, and R.M. Bokhtia. RSC Advances, 2019. 9(35): p. 20450-20462. ISI[000474266800061].
[WOS]. TB_08_2019.
33. No in Vitro Synergistic Effect of Bedaquiline Combined with Fluoroquinolones, Linezolid, and Clofazimine against Extensively Drug-resistant Tuberculosis. Pang, Y., W. Jing, J. Lu, Z. Zong, F. Huo, L. Dong, G. Dai, Y. Li, H. Huang, and N. Chu. Diagnostic Microbiology and Infectious Disease, 2019. 94(4): p. 361-364. PMID[30876684].
[PubMed]. TB_08_2019.
34. Second Generation of Primaquine Ureas and bis-Ureas as Potential Antimycobacterial Agents. Pavic, K., Z. Rajic, H. Michnova, J. Jampilek, I. Perkovic, and B. Zorc. Molecular Diversity, 2019. 23(3): p. 657-667. PMID[30523579].
[PubMed]. TB_08_2019.
35. Synthesis of Rigidified Shikimic acid Derivatives by Ring-closing Metathesis to Imprint Inhibitor Efficacy against Shikimate Kinase Enzyme. Pernas, M., B. Blanco, E. Lence, P. Thompson, A.R. Hawkins, and C. Gonzalez-Bello. Organic Chemistry Frontiers, 2019. 6(14): p. 2514-2528. ISI[000477946500030].
[WOS]. TB_08_2019.
36. The Synthesis and Evaluation of Quinolinequinones as Anti-mycobacterial Agents. Santoso, K.T., A. Menorca, C.Y. Cheung, G.M. Cook, B.L. Stocker, and M.S.M. Timmer. Bioorganic & Medicinal Chemistry, 2019. 27(16): p. 3532-3545. PMID[31262663].
[PubMed]. TB_08_2019.
37. Structure Based Identification of Novel Inhibitors against ATP Synthase of Mycobacterium tuberculosis: A Combined in Silico and in Vitro Study. Shahbaaz, M., R. Cloete, M. Grobbelaar, S. Sampson, and A. Christoffels. International Journal of Biological Macromolecules, 2019. 135: p. 582-590. PMID[31121229].
[PubMed]. TB_08_2019.
38. Discovery of Novel N-methyl Carbazole Tethered Rhodanine Derivatives as Direct Inhibitors of Mycobacterium tuberculosis InhA. Shaikh, M.S., A.M. Kanhed, B. Chandrasekaran, M.B. Palkar, N. Agrawal, C. Lherbet, G.A. Hampannavar, and R. Karpoormath. Bioorganic & Medicinal Chemistry Letters, 2019. 29(16): p. 2338-2344. PMID[31227345].
[PubMed]. TB_08_2019.
39. In Silico and in Vitro Approach of Allium cepa and Isolated Quercetin against MDR Bacterial Strains and Mycobacterium smegmatis. Sharma, D., R. Rani, M. Chaturvedi, P. Rohilla, and J.P. Yadav. South African Journal of Botany, 2019. 124: p. 29-35. ISI[000478678800006].
[WOS]. TB_08_2019.
40. Antibacterial Activity and Mode of Action of a Sulfonamide-based Class of Oxaborole Leucyl-tRNA-Synthetase Inhibitors. Si, Y., S. Basak, Y. Li, J. Merino, J.N. Iuliano, S.G. Walker, and P.J. Tonge. ACS Infectious Diseases, 2019. 5(7): p. 1231-1238. PMID[31007018]. PMCID[PMC6625891].
[PubMed]. TB_08_2019.
41. Click Chemistry Based Regioselective One-pot Synthesis of Coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-Ttiazol-3(4H)-ones as Newer Potent Antitubercular Agents. Somagond, S.M., R.R. Kamble, P.K. Bayannavar, S.K.J. Shaikh, S.D. Joshi, V.M. Kumbar, A.R. Nesaragi, and M.Y. Kariduraganavar. Archiv der Pharmazie, 2019: e1900013. PMID[31397503].
[PubMed]. TB_08_2019.
42. Antimicrobial Substances from the Rare Actinomycete Nonomuraea rhodomycinica NR4-ASC07T. Supong, K., P. Sripreechasak, W. Phongsopitanun, S. Tanasupawat, K. Danwisetkanjana, N. Bunbamrung, and P. Pittayakhajonwut. Natural Product Research, 2019. 33(16): p. 2285-2291. PMID[29451019].
[PubMed]. TB_08_2019.
43. Novel Imidazo[2,1-b][1,3,4]thiadiazole (ITD) Hybrid Compounds: Design, Synthesis, Efficient Antibacterial Activity and Antioxidant Effects. Taflan, E., H. Bayrak, M. Er, S. Alpay Karaoglu, and A. Bozdeveci. Bioorganic Chemistry, 2019. 89: 102998. PMID[31128819].
[PubMed]. TB_08_2019.
44. Antimicrobial and Anti-tubercular Activities of Isolates and Semi-synthetic Derivatives of Lichen Ramalina leiodea (Nyl.) Nyl. Tatipamula, V.B. and G.S. Vedula. Journal of the Serbian Chemical Society, 2019. 84(6): p. 555-562. ISI[000474347000003].
[WOS]. TB_08_2019.
45. Pharmacokinetic-Pharmacodynamic Analysis of the Anti-tuberculosis Antibiotic Isoniazid in Zebrafish Larva in Relation to Its Minimum Inhibitory Concentration. van Wijk, R.C., E.H. Krekels, D.J. van den Berg, R. Bahi, J. Liu, T. Verboom, A.M. van der Sar, U.S. Simonsson, H.P. Spaink, and P.H. van der Graaf. British Journal of Pharmacology, 2019. 176(16): p. 3007-3007. ISI[000475816900058].
[WOS]. TB_08_2019.
46. Biochemical and Microbiological Evaluation of N-aryl Urea Derivatives against Mycobacteria and Mycobacterial Hydrolases. Vartak, A., C. Goins, V.C.N. de Moura, C.M. Schreidah, A.D. Landgraf, B.R. Lin, J.Y. Du, M. Jackson, D.R. Ronning, and S.J. Sucheck. MedChemComm, 2019. 10(7): p. 1197-1204. ISI[000475806000016].
[WOS]. TB_08_2019.
47. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus in vitro and in Macrophages. Viljoen, A., C. Raynaud, M.D. Johansen, F. Roquet-Baneres, J.L. Herrmann, W. Daher, and L. Kremer. Antimicrobial Agents and Chemotherapy, 2019. 63(9): e00705-00719. PMID[31209005].
[PubMed]. TB_08_2019.
48. Bis(Benzoyl) phosphate Inactivators of beta-Lactamase C from Mtb. White, D.S., C.J. Choy, T.W. Moural, S.E. Martin, J. Wang, S. Gargaro, C. Kang, and C.E. Berkman. Bioorganic & Medicinal Chemistry Letters, 2019. 29(16): p. 2116-2118. PMID[31281019].
[PubMed]. TB_08_2019.
49. Development of Inhibitors against Mycobacterium abscessus TRNA (M1G37) Methyltransferase (TrmD) Using Fragment-based Approaches. Whitehouse, A.J., S.E. Thomas, K.P. Brown, A. Fanourakis, D.S. Chan, M.D.J. Libardo, V. Mendes, H.I.M. Boshoff, R.A. Floto, C. Abell, T.L. Blundell, and A.G. Coyne. Journal of Medicinal Chemistry, 2019. 62(15): p. 7210-7232. PMID[31282680]. PMCID[PMC6691401].
[PubMed]. TB_08_2019.
50. Macozinone: Revised Synthesis and Crystal Structure of a Promising New Drug for Treating Drug-sensitive and Drug-resistant Tuberculosis. Zhang, G. and C.C. Aldrich. Acta Crystallographica. Section C, Structural Chemistry, 2019. 75(Pt 8): p. 1031-1035. PMID[31380784].
[PubMed]. TB_08_2019.
Patent Citations
51. Antibacterial Agents: Soluble Salts and Aqueous Formulations of Pyronins. Ebright, R.H. and Y.W. Ebright. Patent. 2019. 2019-US17700 2019160875: 50pp.
[Patent]. TB_08_2019.
52. Antibacterial Agents: O-Alkyl-deuterated pyronins. Ebright, R.H. and Y.W. Ebright. Patent. 2019. 2019-US17697 2019160873: 72pp.
[Patent]. TB_08_2019.
53. Anti-tubercular Composition, and Combinatorial Implementations Thereof. Surolia, A., A. Mishra, A.S. Mamidi, and R.S. Rajmani. Patent. 2019. 2019-IN50138 2019162964: 85pp.
[Patent]. TB_08_2019.